ResMed Inc. Launches Global Sleep Institute, Expands Capabilities through VirtuOx Acquisition

ResMed Inc. (RMD) has launched its Global Sleep Institute at the World Sleep Congress to advance sleep health through partnerships with clinicians, researchers, and policymakers. The initiative aims to address the massive global burden of sleep disorders like obstructive sleep apnea and insomnia. RMD also highlighted research on PAP therapy adherence, gender disparities in OSA diagnosis, and the role of artificial intelligence in enhancing therapy engagement. The company's acquisition of VirtuOx strengthens its ability to provide early diagnosis and connected home-based care.

ResMed Inc. (RMD), a leading health technology company, has made significant strides in advancing sleep health and home care solutions. At the recent World Sleep Congress, ResMed launched its Global Sleep Institute, aiming to address the global burden of sleep disorders such as obstructive sleep apnea (OSA) and insomnia. The initiative seeks to deliver evidence-based insights and drive care innovation through partnerships with clinicians, researchers, policymakers, and health system leaders ResMed Inc. (RMD) Launches Global Sleep Institute at World Sleep Congress^[1].

The Global Sleep Institute focuses on delivering innovative solutions to improve patient outcomes. The company highlighted research on key areas such as PAP therapy adherence, gender disparities in OSA diagnosis, and the role of artificial intelligence in enhancing therapy engagement. These advancements position ResMed as a leader in the health technology sector, reflecting its strong growth potential through innovation in both devices and digital health solutions ResMed Inc. (RMD) Launches Global Sleep Institute at World Sleep Congress^[1].

In addition to its new initiative, ResMed has further expanded its capabilities through the acquisition of VirtuOx, an independent diagnostic testing facility specializing in at-home diagnostics for sleep, respiratory, and cardiac conditions. This acquisition strengthens ResMed's ability to provide early diagnosis and connected home-based care, simplifying patient access while supporting better health outcomes ResMed Inc. (RMD) Launches Global Sleep Institute at World Sleep Congress^[1].

ResMed's acquisition of VirtuOx aligns with its long-term strategy to capture a larger share of the diagnosis-to-therapy funnel. Improved access to at-home testing and digital screening with VirtuOx supports efforts to boost patient flow and enhance overall health outcomes What ResMed (RMD)'s VirtuOx Acquisition and Q4 Growth Reveal About Its Evolving Strategy^[2].

ResMed's investment narrative is centered around its ability to expand its leadership across sleep health, capitalize on long-term demand for treatment, and sustain technological and diagnostic innovation. The recent World Sleep Congress presentation and Q4 2025 results reaffirm management’s progress with product growth, but the company remains exposed to ongoing competitive pressures What ResMed (RMD)'s VirtuOx Acquisition and Q4 Growth Reveal About Its Evolving Strategy^[2].

The acquisition of VirtuOx and the launch of the Global Sleep Institute underscore ResMed's commitment to innovation and improving patient outcomes. As the company continues to innovate in both devices and digital health solutions, investors should monitor its progress and potential risks, such as new therapies that could reduce device demand if adoption accelerates What ResMed (RMD)'s VirtuOx Acquisition and Q4 Growth Reveal About Its Evolving Strategy^[2].

ResMed's outlook forecasts $6.4 billion in revenue and $1.9 billion in earnings by 2028, based on an expected annual revenue growth rate of 7.8% and an earnings increase of $0.5 billion from current earnings of $1.4 billion What ResMed (RMD)'s VirtuOx Acquisition and Q4 Growth Reveal About Its Evolving Strategy^[2]. The company's fair value estimates vary, with eight estimates from the Simply Wall St Community spanning US$179.72 to US$291.86 per share, reflecting highly varied outlooks What ResMed (RMD)'s VirtuOx Acquisition and Q4 Growth Reveal About Its Evolving Strategy^[2].

In conclusion, ResMed Inc. is positioned to continue its growth trajectory through innovation and strategic acquisitions. The launch of the Global Sleep Institute and the acquisition of VirtuOx demonstrate the company's commitment to addressing the global burden of sleep disorders and improving patient outcomes. Investors should closely monitor ResMed's progress and potential risks to make informed investment decisions.